Literature DB >> 26819916

Effects of Environmental Factors on Soluble Expression of a Humanized Anti-TNF-α scFv Antibody in Escherichia coli.

Mohammad Sina1, Davoud Farajzadeh2, Siavoush Dastmalchi3.   

Abstract

PURPOSE: The bacterial cultivation conditions for obtaining anti-TNF-α single chain variable fragment (scFv) antibody as the soluble product in E. coli was investigated.
METHODS: To avoid the production of inclusion bodies, the effects of lactose, IPTG, incubation time, temperature, shaking protocol, medium additives (Mg+2, sucrose), pH, osmotic and heat shocks were examined. Samples from bacterial growth conditions with promising results of soluble expression of GST-hD2 scFv were affinity purified and quantified by SDS-PAGE and image processing for further evaluation.
RESULTS: The results showed that cultivation in LB medium under induction by low concentrations of lactose and incubation at 10 °C led to partial solubilization of the expressed anti-TNF-α scFv (GST-hD2). Other variables which showed promising increase in soluble expression of GST-hD2 were osmotic shock and addition of magnesium chloride. Furthermore, addition of sucrose to medium suppressed the expression of scFv completely. The other finding was that the addition of sorbitol decreased the growth rate of bacteria.
CONCLUSION: It can be concluded that low cultivation temperature in the presence of low amount of inducer under a long incubation time or addition of magnesium chloride are the most effective environmental factors studied for obtaining the maximum solubilization of GST-hD2 recombinant protein.

Entities:  

Keywords:  Escherichia coli; Growth optimization; Inclusion bodies; Recombinant protein expression; Single-chain antibodies; Tumor necrosis factor-alpha

Year:  2015        PMID: 26819916      PMCID: PMC4729350          DOI: 10.15171/apb.2015.062

Source DB:  PubMed          Journal:  Adv Pharm Bull        ISSN: 2228-5881


  30 in total

1.  Characterization of the neutralizing activity of three anti-human TNF monoclonal antibodies and prediction of their TNF epitopes by molecular modeling and mutant protein approach.

Authors:  Cansheng Zhu; Xuesong Liu; Jiannan Feng; Wei Zhang; Beifen Shen; Weiming Ou'yang; Yunxin Cao; Boquan Jin
Journal:  Immunol Lett       Date:  2005-10-04       Impact factor: 3.685

2.  Recombinant protein solubility - does more mean better?

Authors:  Nuria González-Montalbán; Elena García-Fruitós; Antonio Villaverde
Journal:  Nat Biotechnol       Date:  2007-07       Impact factor: 54.908

3.  High level production of soluble single chain antibodies in small-scale Escherichia coli cultures.

Authors:  S M Kipriyanov; G Moldenhauer; M Little
Journal:  J Immunol Methods       Date:  1997-01-15       Impact factor: 2.303

4.  Overproduction of anti-Tn antibody MLS128 single-chain Fv fragment in Escherichia coli cytoplasm using a novel pCold-PDI vector.

Authors:  Ganesh P Subedi; Tadashi Satoh; Shinya Hanashima; Akemi Ikeda; Hiroshi Nakada; Reiko Sato; Mamoru Mizuno; Noriyuki Yuasa; Yoko Fujita-Yamaguchi; Yoshiki Yamaguchi
Journal:  Protein Expr Purif       Date:  2012-01-08       Impact factor: 1.650

5.  Coexpression of molecular chaperones to enhance functional expression of anti-BNP scFv in the cytoplasm of Escherichia coli for the detection of B-type natriuretic peptide.

Authors:  Bo Hee Maeng; Dong Hyun Nam; Yong Hwan Kim
Journal:  World J Microbiol Biotechnol       Date:  2010-10-20       Impact factor: 3.312

Review 6.  Development of anti-TNF therapy for rheumatoid arthritis.

Authors:  Marc Feldmann
Journal:  Nat Rev Immunol       Date:  2002-05       Impact factor: 53.106

7.  Optimizing the expression of a monoclonal antibody fragment under the transcriptional control of the Escherichia coli lac promoter.

Authors:  R S Donovan; C W Robinson; B R Glick
Journal:  Can J Microbiol       Date:  2000-06       Impact factor: 2.419

8.  A mutation that improves soluble recombinant hemoglobin accumulation in Escherichia coli in heme excess.

Authors:  M J Weickert; M Pagratis; C B Glascock; R Blackmore
Journal:  Appl Environ Microbiol       Date:  1999-02       Impact factor: 4.792

9.  Secretion of a functional Fab fragment in Escherichia coli and the influence of culture conditions.

Authors:  T Shibui; K Nagahari
Journal:  Appl Microbiol Biotechnol       Date:  1992-06       Impact factor: 4.813

Review 10.  scFv antibody: principles and clinical application.

Authors:  Zuhaida Asra Ahmad; Swee Keong Yeap; Abdul Manaf Ali; Wan Yong Ho; Noorjahan Banu Mohamed Alitheen; Muhajir Hamid
Journal:  Clin Dev Immunol       Date:  2012-03-15
View more
  12 in total

1.  Improved production of the recombinant phospholipase A1 from Polybia paulista wasp venom expressed in bacterial cells for use in routine diagnostics.

Authors:  Amilcar Perez-Riverol; Alexis Musacchio-Lasa; Luis Gustavo Romani Fernandes; Jose Roberto Aparecido Dos Santos-Pinto; Franciele Grego Esteves; Murilo Luiz Bazon; Ricardo de Lima Zollner; Mario Sergio Palma; Márcia Regina Brochetto-Braga
Journal:  3 Biotech       Date:  2020-04-27       Impact factor: 2.406

2.  Mechanistic platform knowledge of concomitant sugar uptake in Escherichia coli BL21(DE3) strains.

Authors:  David J Wurm; Johanna Hausjell; Sophia Ulonska; Christoph Herwig; Oliver Spadiut
Journal:  Sci Rep       Date:  2017-03-23       Impact factor: 4.379

3.  Design and Construction of a Novel Humanized Single-Chain Variable-Fragment Antibody Against the Tumor Necrosis Factor Alpha.

Authors:  Davoud Farajzadeh; Sadigheh Karimi-Gharigh; Parisa Jalali-Kondori; Siavoush Dastmalchi
Journal:  Iran J Pharm Res       Date:  2019       Impact factor: 1.696

4.  The Effects of Lactose Induction on a Plasmid-Free E. coli T7 Expression System.

Authors:  Johanna Hausjell; Regina Kutscha; Jeannine D Gesson; Daniela Reinisch; Oliver Spadiut
Journal:  Bioengineering (Basel)       Date:  2020-01-06

Review 5.  Challenges Associated With the Formation of Recombinant Protein Inclusion Bodies in Escherichia coli and Strategies to Address Them for Industrial Applications.

Authors:  Arshpreet Bhatwa; Weijun Wang; Yousef I Hassan; Nadine Abraham; Xiu-Zhen Li; Ting Zhou
Journal:  Front Bioeng Biotechnol       Date:  2021-02-10

6.  Statistical optimization of culture conditions for expression of recombinant humanized anti-EpCAM single-chain antibody using response surface methodology.

Authors:  Aidin Behravan; Atieh Hashemi
Journal:  Res Pharm Sci       Date:  2021-03-05

7.  Machine learning modeling for solubility prediction of recombinant antibody fragment in four different E. coli strains.

Authors:  Atieh Hashemi; Majid Basafa; Aidin Behravan
Journal:  Sci Rep       Date:  2022-03-31       Impact factor: 4.379

8.  Teaching an old pET new tricks: tuning of inclusion body formation and properties by a mixed feed system in E. coli.

Authors:  David J Wurm; Julian Quehenberger; Julia Mildner; Britta Eggenreich; Christoph Slouka; Andreas Schwaighofer; Karin Wieland; Bernhard Lendl; Vignesh Rajamanickam; Christoph Herwig; Oliver Spadiut
Journal:  Appl Microbiol Biotechnol       Date:  2017-11-20       Impact factor: 4.813

9.  E. coli HMS174(DE3) is a sustainable alternative to BL21(DE3).

Authors:  Johanna Hausjell; Julia Weissensteiner; Christian Molitor; Heidi Halbwirth; Oliver Spadiut
Journal:  Microb Cell Fact       Date:  2018-10-30       Impact factor: 5.328

Review 10.  Evolution of Escherichia coli Expression System in Producing Antibody Recombinant Fragments.

Authors:  Annamaria Sandomenico; Jwala P Sivaccumar; Menotti Ruvo
Journal:  Int J Mol Sci       Date:  2020-08-31       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.